ABBOTT LABORATORIES — Director's Dealing 2023

Dec 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2023-12-14

Reporting Person: Wainer Andrea F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-14	Common shares without par value	M	15000	$44.40	Acquired	80027	Direct
2023-12-14	Common shares without par value	S	15000	$108	Disposed	65027	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-14	Option (right to buy)	$44.40	M	15000	Disposed	2027-02-16	Common Shares (15000)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.